Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (2): 159-165.doi: 10.3969/j.issn.1000-6621.2021.02.011
• Original Articles • Previous Articles Next Articles
WANG Xiu-jun, LIU Qiu-yue, CHEN Xiao-feng, YU Lei, MA Yan, HAN Fen()
Received:
2020-10-23
Online:
2021-02-10
Published:
2021-02-03
Contact:
HAN Fen
E-mail:lmegi@163.com
WANG Xiu-jun, LIU Qiu-yue, CHEN Xiao-feng, YU Lei, MA Yan, HAN Fen. Study on plasma proteomics of patients with secondary pulmonary tuberculosis based on label-free quantitative technology[J]. Chinese Journal of Antituberculosis, 2021, 43(2): 159-165. doi: 10.3969/j.issn.1000-6621.2021.02.011
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2021.02.011
GO ID | 分子功能名称 | 富集的差异蛋白个数 | 构成比(%) | |
---|---|---|---|---|
GO:0003676 | 核酸结合(nucleic acid binding) | 127 | 9.32 | |
GO:0003774 | 运动活动(motor activity) | 26 | 1.91 | |
GO:0003824 | 催化活性(catalytic activity) | 20 | 1.47 | |
GO:0004386 | helicase activity | 5 | 0.37 | |
GO:0004871 | 信号传感器活动(signal transducer activity) | 42 | 3.08 | |
GO:0004872 | 受体活性(receptor activity) | 40 | 2.94 | |
GO:0005198 | 结构分子活性(structural molecule activity) | 30 | 2.20 | |
GO:0005215 | 转运活性(transporter activity) | 31 | 2.27 | |
GO ID | 分子功能名称 | 富集的差异蛋白个数 | 构成比(%) | |
GO:0005488 | 结合(binding) | 406 | 29.79 | |
GO:0005515 | 蛋白质结合(protein binding) | 338 | 24.80 | |
GO:0008565 | 蛋白质转运体活性(protein transporter activity) | 4 | 0.29 | |
GO:0009055 | 电子载流子活性(electron carrier activity) | 4 | 0.29 | |
GO:0015075 | 离子跨膜转运活性(ion transmembrane transporter activity) | 15 | 1.10 | |
GO:0015267 | 通道活动(channel activity) | 12 | 0.88 | |
GO:0016209 | 抗氧化活性(antioxidant activity) | 4 | 0.29 | |
GO:0016301 | 激酶活性(kinase activity) | 43 | 3.16 | |
GO:0016491 | 氧化还原酶活性(oxidoreductase activity) | 19 | 1.39 | |
GO:0016740 | 转移酶活性(transferase activity) | 73 | 5.36 | |
GO:0016787 | 水解酶活性(hydrolase activity) | 74 | 5.43 | |
GO:0016829 | 裂解酶活性(lyase activity) | 7 | 0.51 | |
GO:0016853 | 异构酶活性(isomerase activity) | 7 | 0.51 | |
GO:0016874 | 连接酶活性(ligase activity) | 4 | 0.29 | |
GO:0030234 | 酶调节活性(enzyme regulator activity) | 32 | 2.35 |
GO ID | 生物进程名称 | 富集的差异蛋白个数 | 构成比(%) |
---|---|---|---|
GO:0006139 | 含核碱化合物代谢过程(nucleobase-containing compound metabolic process) | 164 | 5.18 |
GO:0006520 | 细胞氨基酸代谢过程(cellular amino acid metabolic process) | 10 | 0.32 |
GO:0006810 | 运输(transport) | 160 | 5.05 |
GO:0006928 | 细胞或亚细胞成分的运动(movement of cell or subcellular component) | 82 | 2.59 |
GO:0006944 | 膜融合(membrane fusion) | 7 | 0.22 |
GO:0007154 | 细胞通讯(cell communication) | 169 | 5.34 |
GO:0007275 | 多细胞生物发育(multicellular organism development) | 146 | 4.61 |
GO:0007610 | 行为(behavior) | 19 | 0.60 |
GO:0008152 | 代谢过程(metabolic process) | 352 | 11.11 |
GO:0008219 | 细胞死亡(cell death) | 70 | 2.21 |
GO:0009056 | 分解代谢过程(catabolic process) | 62 | 1.96 |
GO:0009058 | 生物合成过程(biosynthetic process) | 167 | 5.27 |
GO:0009987 | 细胞过程(cellular process) | 467 | 14.75 |
GO:0030154 | 细胞分化(cell differentiation) | 121 | 3.82 |
GO:0032501 | 大分子代谢过程(multicellular organismal process) | 163 | 5.15 |
GO:0043062 | 细胞外结构组织(extracellular structure organization) | 22 | 0.69 |
GO:0043170 | 大分子代谢过程(macromolecule metabolic process) | 298 | 9.41 |
GO:0046903 | 分泌物(secretion) | 57 | 1.80 |
GO:0050789 | 生物过程调控(regulation of biological process) | 336 | 10.61 |
GO:0050896 | 刺激反应(response to stimulus) | 235 | 7.42 |
GO:0051704 | 多生物过程(multi-organism process) | 60 | 1.89 |
GO ID | 细胞定位名称 | 富集的差异蛋白个数 | 构成比(%) |
---|---|---|---|
GO:0005576 | 胞外区(extracellular region) | 129 | 7.32 |
GO:0005578 | 蛋白质细胞外基质(proteinaceous extracellular matrix) | 30 | 1.70 |
GO:0005615 | 细胞外间隙(extracellular space) | 61 | 3.46 |
GO:0005622 | 细胞内(intracellular) | 389 | 22.07 |
GO:0005623 | 细胞(cell) | 388 | 22.01 |
GO:0005634 | 核(nucleus) | 207 | 11.74 |
GO:0005694 | 染色体 (chromosome) | 27 | 1.53 |
GO:0005737 | 细胞质(cytoplasm) | 298 | 16.90 |
GO:0009986 | 细胞表面(cell surface) | 17 | 0.96 |
GO:0016020 | 膜(membrane) | 217 | 12.31 |
通路名称 | 通路编码 | 通路数 | 链接 | |||
---|---|---|---|---|---|---|
上调通路 | ||||||
背腹轴形成通路(dorso-ventral axis formation) | hsa04320 | 8 | http://www.genome.jp/kegg-bin/show_pathway?hsa04320/hsa:6654%09red/hsa:440822%09red/hsa:143689%09red/hsa:4853%09red/hsa:673%09red | |||
黏着斑通路(focal adhesion) | hsa04510 | 21 | http://www.genome.jp/kegg-bin/show_pathway?hsa04510/hsa:3480%09red/hsa:3918%09red/hsa:7448%09red/hsa:5582%09red/hsa:1286%09red/hsa:673%09red/hsa:57144%09red/hsa:5293%09red/hsa:9564%09red/hsa:2335%09red/hsa:6654%09red/hsa:81%09red/hsa:284217%09red/hsa:7148%09red | |||
癌症蛋白多糖通路(proteoglycans in cancer) | hsa05205 | 20 | http://www.genome.jp/kegg-bin/show_pathway?hsa05205/hsa:2817%09red/hsa:7477%09red/hsa:5293%09red/hsa:5582%09red/hsa:7099%09red/hsa:6194%09red/hsa:7448%09red/hsa:2335%09red/hsa:6654%09red/hsa:2065%09red/hsa:673%09red/hsa:3480%09red/hsa:3236%09red/hsa:3710%09red/hsa:7484%09red | |||
血小板活化通路(platelet activation) | hsa04611 | 13 | http://www.genome.jp/kegg-bin/show_pathway?hsa04611/hsa:3710%09red/hsa:2243%09red/hsa:5293%09red/hsa:2244%09red/hsa:111%09red/hsa:5028%09red/hsa:4067%09red | |||
ECM受体相互作用(ECM-receptor interaction) | hsa04512 | 10 | http://www.genome.jp/kegg-bin/show_pathway?hsa04512/hsa:3918%09red/hsa:1286%09red/hsa:7448%09red/hsa:2335%09red/hsa:284217%09red/hsa:7148%09red | |||
补体途径凝血通路(complement and coagulation cascades) | hsa04610 | 9 | http://www.genome.jp/kegg-bin/show_pathway?hsa04610/hsa:3827%09red/hsa:2243%09red/hsa:7448%09red/hsa:2244%09red/hsa:2157%09red/hsa:717%09red/hsa:716%09red | |||
癌症小RNA通路(MicroRNAs in cancer) | hsa05206 | 14 | http://www.genome.jp/kegg-bin/show_pathway?hsa05206/hsa:1789%09red/hsa:5582%09red/hsa:3236%09red/hsa:6654%09red/hsa:2065%09red/hsa:4853%09red/hsa:324%09red/hsa:7148%09red | |||
非洲嗜睡病通路(African trypanosomiasis) | hsa05143 | 6 | http://www.genome.jp/kegg-bin/show_pathway?hsa05143/hsa:3043%09red/hsa:3040%09red/hsa:5582%09red/hsa:3250%09red | |||
通路名称 | 通路编码 | 通路数 | 链接 | |||
mTOR 信号通路(mTOR signaling pathway) | hsa04150 | 13 | http://www.genome.jp/kegg-bin/show_pathway?hsa04150/hsa:7477%09red/hsa:3480%09red/hsa:5582%09red/hsa:673%09red/hsa:6194%09red/hsa:5293%09red/hsa:27330%09red/hsa:6654%09red/hsa:7484%09red/hsa:6520%09red/hsa:6249%09red | |||
ErbB 信号通路(ErbB signaling pathway) | hsa04012 | 10 | http://www.genome.jp/kegg-bin/show_pathway?hsa04012/hsa:685%09red/hsa:5582%09red/hsa:673%09red/hsa:57144%09red/hsa:5293%09red/hsa:6654%09red/hsa:2065%09red | |||
EGFR酪氨酸激酶抑制剂抵抗通路(EGFR tyrosine kinase inhibitor resistance) | hsa01521 | 9 | http://www.genome.jp/kegg-bin/show_pathway?hsa01521/hsa:3480%09red/hsa:5582%09red/hsa:673%09red/hsa:6194%09red/hsa:5293%09red/hsa:6654%09red/hsa:2065%09red | |||
长时程抑制通路(Long-term depression) | hsa04730 | 8 | http://www.genome.jp/kegg-bin/show_pathway?hsa04730/hsa:3480%09red/hsa:673%09red/hsa:4067%09red/hsa:5582%09red/hsa:3710%09red | |||
阿米巴通路(Amoebiasis) | hsa05146 | 10 | http://www.genome.jp/kegg-bin/show_pathway?hsa05146/hsa:3918%09red/hsa:5582%09red/hsa:1286%09red/hsa:7099%09red/hsa:5293%09red/hsa:2335%09red/hsa:81%09red/hsa:284217%09red | |||
内分泌抵抗通路(endocrine resistance) | hsa01522 | 10 | http://www.genome.jp/kegg-bin/show_pathway?hsa01522/hsa:5293%09red/hsa:673%09red/hsa:3480%09red/hsa:6654%09red/hsa:111%09red/hsa:4853%09red | |||
肾细胞癌通路(renal cell carcinoma) | hsa05211 | 8 | http://www.genome.jp/kegg-bin/show_pathway?hsa05211/hsa:6654%09red/hsa:57144%09red/hsa:5293%09red/hsa:2271%09red/hsa:673%09red | |||
PI3K-Akt信号通路(PI3K-Akt signaling pathway) | hsa04151 | 21 | http://www.genome.jp/kegg-bin/show_pathway?hsa04151/hsa:7533%09red/hsa:3918%09red/hsa:7448%09red/hsa:1286%09red/hsa:7099%09red/hsa:6194%09red/hsa:5293%09red/hsa:2335%09red/hsa:6654%09red/hsa:3815%09red/hsa:284217%09red/hsa:3480%09red/hsa:7148%09red | |||
磷脂酰肌醇信号系统(phosphatidylinositol signaling system) | hsa04070 | 9 | http://www.genome.jp/kegg-bin/show_pathway?hsa04070/hsa:5293%09red/hsa:5287%09red/hsa:5582%09red/hsa:3710%09red | |||
下调通路 | ||||||
肌动蛋白细胞骨架的调节通路(regulation of actin cytoskeleton) | hsa04810 | 14 | http://www.genome.jp/kegg-bin/show_pathway?hsa04810/hsa:2934%09red/hsa:673%09red/hsa:57144%09red/hsa:5293%09red/hsa:79784%09red/hsa:9564%09red/hsa:2335%09red/hsa:6654%09red/hsa:81%09red/hsa:324%09red |
[1] | World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020. |
[2] | Zhang X, Liang Z, Zhang Y, et al. Comprehensive analysis of long non-coding RNAs expression pattern in the pathogenesis of pulmonary tuberculosis. Genomics, 2020,112(2):1970-1977. doi: 10.1016/j.ygeno.2019.11.009. |
[3] | Zetter M, Barrios-Payán J, Mata-Espinosa D, et al. Involvement of Vasopressin in the Pathogenesis of Pulmonary Tuberculosis: A New Therapeutic Target? Front Endocrinol (Lausanne), 2019,10:351. doi: 10.3389/fendo.2019.00351. |
[4] | Nahnsen S, Bielow C, Reinert K, et al. Tools for label-free peptide quantification. Mol Cell Proteomics, 2013,12(3):549-556. doi: 10.1074/mcp.R112.025163. |
[5] | Ghafourian S, Sekawi Z, Raftari M, et al. Application of proteomics in lab diagnosis. Clin Lab, 2013,59(5/6):465-474. |
[6] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断. 2017-11-09. |
[7] | Hanash S. A call for a fresh new look at the plasma proteome. Proteomics Clin Appl, 2012,6(9/10):443-446. doi: 10.1002/prca.201200052. |
[8] | Claydon AJ, Beynon R. Proteome dynamics: revisiting turnover with a global perspective. Mol Cell Proteomics, 2012,11(12):1551-1565. doi: 10.1074/mcp.O112.022186. |
[9] | Garbis SD, Townsend PA. Proteomics of human prostate cancer biospecimens: the global, systems-wide perspective for protein markers with potential clinical utility. Expert Rev Proteomics, 2013,10(4):337-354. doi: 10.1586/14789450.2013.827408. |
[10] | Lee PL, Jerng JS, Chang YL, et al. Patient mortality of active pulmonary tuberculosis requiring mechanical ventilation. Eur Respir J, 2003,22(1):141-147. doi: 10.1183/09031936.03.00038703. |
[11] | Wallis RS, Pai M, Menzies D, et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet, 2010,375(9729):1920-1937. doi: 10.1016/S0140-6736(10)60359-5. |
[12] | 吴艺舟, 严雨欣, 孙杰. 黏着斑信号通路调控肿瘤上皮间质转化的研究进展. 医学理论与实践, 2015,28(19):2601-2604. |
[13] | Nishi K, Maruyama T, Halsall HB, et al. Binding of alpha1-acid glycoprotein to membrane results in a unique structural change and ligand release. Biochemistry, 2004,43(32):10513-10519. doi: 10.1021/bi0400204. |
[1] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[2] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[3] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[4] | Huang Misun, Wu Yaning, Li Guilian, Liu Haican. Research advances of Mycobacterium tuberculosis enrichment technology [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 369-373. |
[5] | Zhang Chao, Yu Xia, Huang Hairong, Liu Wei, Liu Tao. Evaluation of the in vitro antimicrobial effects of sevoflurane on Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 158-163. |
[6] | Fu Ying, Xiong Yangyang, Fang Si, Li Chuanxiang, Guo Hongrong. The research progress on the relationship between serum albumin and its derivative biomarkers and chronic obstructive pulmonary disease [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 231-236. |
[7] | Liu Ruihua, Sarina , Wang Furong. Interaction between lung cancer and tuberculosis in disease development and progression [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 102-111. |
[8] | Chen Jifei, Huang Lihua, Luo Lanbo, Sui Wenxian, Pang Yu, Liu Aimei. Evaluation the efficacy of tongue swab-based PCR fluorescence probe method for pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 51-60. |
[9] | Lu Hailin, Wang Wenfei, Tao Wenhui, Lin Peicong, Chen Xinchun, Deng Guofang, Xie Shuixiang. Oleic acid upregulates the expression of perilipin 2 enhancing macrophage clearance of Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 72-76. |
[10] | Wang Yilin, Wu Xiao, Pang Yu, Li Shanshan. Immunomodulatory effect of orelabrutinib in host macrophages infected with mycobacterium [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1063-1068. |
[11] | Palidanguli Abudureheman, Wang Senlu, Gulina Badeerhan, Wang Le, Zulikatiayi Abudula, Wang Xinqi, Maiwulajiang Yimamu, Wang Xijiang. Distribution of Mycobacterium tuberculosis genotypes in Kashgar region and their association with clinical characteristics of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1077-1082. |
[12] | Xu Chunhua, Zhu Shiyu, Hu Yi, Yi Kehua, Song Canlei, Wang Zichun, Wu Yong, Wang Qing, Yang Qianru, Shen Xin. Analysis of screening effect of recombinant Mycobacterium tuberculosis fusion protein in screening Mycobacterium tuberculosis infection in close contacts of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 897-902. |
[13] | Zhang Lanyue, Wang Yingchao, Liu Weiyi, Shang Xuetian, Jia Hongyan, Zhu Chuanzhi, Zhang Zongde, Pan Liping. Study on the effect of thiol acetyltransferase mshD on the growth and stress response of Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 935-941. |
[14] | Yu Lan, Chen Shuangshuang, Wang Nenhan, Tian Lili, Zhao Yanfeng, Fan Ruifang, Liu Haican, Li Chuanyou, Dai Xiaowei. Consistency between phenotypic resistance to fluoroquinolones and genetic mutations in rifampicin resistant Mycobacterium tuberculosis strains [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 942-950. |
[15] | He Xiangrong, Chen Hua, Chen Pinru, Liang Feng, Ren Huili, Zhu Jialou, Hu Jinxing, Tan Yaoju. A case report and literature review of Mycobacterium asiaticum pulmonary disease [J]. Chinese Journal of Antituberculosis, 2024, 46(7): 763-769. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||